Campaigns 50 celebrity healthcare endorsements

50 celebrity healthcare endorsements

Here's Jon Bon Jovi for Advil, Arnold Palmer for Xarelto and 48 more past and present celebrity endorsements of drugs, healthcare products and disease awareness campaigns.

Campaigns 15 unexpected Twitter responses to the "Who Pneu?" campaign

15 unexpected Twitter responses to the "Who Pneu?" campaign

Celebrity success or fail? Here's what the American Lung Association, Pfizer and Tim Daly likely did not see coming when they joined forces to raise awareness about pneumococcal pneumonia.

Campaigns The best and worst celebrity pharma moments

The best and worst celebrity pharma moments

Heaven knows the industry is itself to blame for some of the dopier recurring imagery in its DTC spots, like models clad in white linen riding horses on deserted stretches of beach.

Campaigns Celebrity drug ads: Opportunity or PR disaster?

Celebrity drug ads: Opportunity or PR disaster?

Tapping celebrities for brand or awareness campaigns ensures a high degree of attention, but such arrangements come with concerns that "regular" ones do not.

Agency Medical Advertising Hall of Fame inductees of 2016

Medical Advertising Hall of Fame inductees of 2016

A pharma research forefather. An agency builder. A "guy you wanted in the room." These Medical Advertising Hall of Fame inductees are a professionally diverse and richly worthy trio.

Payer/Managed Markets With PCSK9s, payers say, 'Let the market decide'

With PCSK9s, payers say, 'Let the market decide'

It's possible that payers won't prove the wild card in the PCSK9 derby. Instead, physician preference may do more to shape the market and maybe even force payers' hands.

Commercial Medicines360 CEO battles for IUD access

Medicines360 CEO battles for IUD access

Prior to Medicines360's arrival on the scene, there were only three IUDs on the market. The lack of competition drove prices sky-high.

Pipeline

Top 25 metabolic products, 2014-2015

Sanofi is the category leader. Its product, Lantus Solostar, brought in $5.27 billion in US sales between October 2014 and September 2015.

Pipeline Diabetes R&D narrows in on glycemic control

Diabetes R&D narrows in on glycemic control

New entrants in the type 2 diabetes treatment market share a similar goal: To solve patients' constant struggle with glycemic control.

Commercial Marketing challenges remain in crowded metabolic market

Marketing challenges remain in crowded metabolic market

Experts insist that R&D efforts in the category must mirror educational campaigns and lifestyle changes, and quickly.

Features Read the complete January 2016 Digital Edition

Read the complete January 2016 Digital Edition

Click the link below to access the Digital Edition of the January 2016 issue of MM&M, with all text, charts and pictures.

Top 40 Transformers Ryan Olohan

Ryan Olohan

Ryan Olohan, National industry director, healthcare, Google

Top 40 Transformers Halle Tecco

Halle Tecco

Halle Tecco, Managing director, Rock Health

Top 40 Transformers Dr. Robert Wachter

Dr. Robert Wachter

Dr. Robert Wachter, Professor, chief of the division of hospital medicine, University of California, San Francisco

Top 40 Transformers Ruchin Kansal

Ruchin Kansal

Ruchin Kansal, Executive director and head, business innovation, Boehringer Ingelheim

Top 40 Transformers Aschkan Abdul Malek

Aschkan Abdul Malek

Aschkan Abdul Malek, CEO/co-founder, AlemHealth

Top 40 Transformers Walter De Brouwer

Walter De Brouwer

Walter De Brouwer, Founder and CEO, Scanadu

Top 40 Transformers Stephanie Bova

Stephanie Bova

Stephanie Bova, Senior director, Takeda Digital Accelerator, Takeda

Top 40 Transformers Meg Columbia-Walsh

Meg Columbia-Walsh

Meg Columbia-Walsh, Global lead, digital healthcare, Cognizant

Top 40 Transformers Zen Chu

Zen Chu

Entrepreneur in residence, Martin Trust Center for MIT

Top 40 Transformers Michael Vinegra

Michael Vinegra

Michael Vinegar, director, medical e-strategy, Novartis

Top 40 Transformers Sandra Elliott

Sandra Elliott

Sandra Elliott, VP, consumer technology and service development, Meridian Health

Top 40 Transformers Dr. Somair Riaz

Dr. Somair Riaz

Dr. Somair Riaz, Founder, Skindroid

Top 40 Transformers Dave Guiga

Dave Guiga

Dave Guiga, senior director, external partnerships & commercial innovations, AstraZeneca

Top 40 Transformers T. J. Parker

T. J. Parker

T. J. Parker, CEO and co-founder, PillPack

Top 40 Transformers Ronald Weidner

Ronald Weidner

Ronald Weidner, Founder and CEO, empower

Top 40 Transformers Anish Sebastian

Anish Sebastian

Anish Sebastian, CEO and co-founder, BabyScripts

Top 40 Transformers Chuck Gershman

Chuck Gershman

Chuck Gershman, Co-founder, president and COO, Kuveda

Top 40 Transformers Nirinjan Yee

Nirinjan Yee

Nirinjan Yee, CEO and founder, BreathResearch

Top 40 Transformers Sonny Vu

Sonny Vu

Sonny Vu, CEO, chairman, founder, Misfit

Top 40 Transformers Judy Sewards

Judy Sewards

Judy Sewards, VP, digital strategy and data innovation, Pfizer

Top 40 Transformers Naomi Fried

Naomi Fried

Naomi Fried, Former chief innovation officer, Boston Children's Hospital

Top 40 Transformers Dr. Noah Craft

Dr. Noah Craft

Dr. Noah Craft, Co-founder and CEO, Science 37

Top 40 Transformers Lucy Rose

Lucy Rose

Lucy Rose, President/owner, Lucy Rose & Associates

Top 40 Transformers Fay Christodoulou

Fay Christodoulou

Fay Christodoulou, chief scientific officer, Miroculus

Top 40 Transformers Jason Bornhorst

Jason Bornhorst

Jason Bornhorst, CEO/co-founder, Patient IO

Top 40 Transformers Kevin Sayer

Kevin Sayer

Kevin Sayer, President and CEO, Dexcom

Top 40 Transformers Greg Cohen

Greg Cohen

Greg Cohen, associate director of global strategic marketing, UCB

Top 40 Transformers Risa Wexler

Risa Wexler

Risa Wexler, Senior director of media and US digital acceleration, Pfizer

Top 40 Transformers Dr. Diego Miralles

Dr. Diego Miralles

Dr. Diego Miralles, Global head of innovation, Janssen

Top 40 Transformers Bronwyn Spira

Bronwyn Spira

Bronwyn Spira, Founder and CEO, FORCE Therapeutics

Top 40 Transformers Kurt Brenkus

Kurt Brenkus

Kurt Brenkus, Founder and CEO, Aver

Top 40 Transformers Sander Flaum

Sander Flaum

Sander Flaum, Principal, Flaum Navigators

Top 40 Transformers Markus Christen

Markus Christen

Markus Christen, Head of global development, Proteus Digital Health

Top 40 Transformers Rob Royea

Rob Royea

Rob Royea, CEO and chairman, Cyrcadia Health

Top 40 Transformers Amy Landucci

Amy Landucci

Amy Landucci, Global head of digital medicines, Novartis

Top 40 Transformers Jörn Aldag

Jörn Aldag

Jörn Aldag, Former CEO, uniQure

Top 40 Transformers Sara Colantonio

Sara Colantonio

Sara Colantonio, Project coordinator, Semeoticons

Top 40 Transformers Ryan Beckland

Ryan Beckland

Ryan Beckland, Co-founder and CEO, Validic

Top 40 Transformers Jane Sarasohn-Kahn

Jane Sarasohn-Kahn

Jane Sarasohn-Kahn, Founder, THINK-Health

Top 40 Transformers Michelle Crouthamel

Michelle Crouthamel

Michelle Crouthamel, Project manager, GlaxoSmithKline

Top 40 Transformers MM&M's Top 40 Healthcare Transformers of 2016

MM&M's Top 40 Healthcare Transformers of 2016

Here are the 40 executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.

Features Marc Iskowitz: Our Own Golden Era Has Begun

Marc Iskowitz: Our Own Golden Era Has Begun

January marks the start of the 50th annual publication cycle of MM&M. We're also witnessing the industry enter its own technological golden era.

Features Superheroes headline shampoo ad in Ecuador

Superheroes headline shampoo ad in Ecuador

Dina Peck's Private View: It's a new year. Let's all commit to creating work in 2016 that inspires.

Features A Faster FDA Approval Rate Key to Price Debate

A Faster FDA Approval Rate Key to Price Debate

Apparently, Dr. Ezekiel Emanuel loves to open his window and shout "fire!"

Features Why Amazon's Echo Device Is Good for Healthcare

Why Amazon's Echo Device Is Good for Healthcare

Amazon's Echo—a voice-activated personal assistant like Siri—has been available to the public for a year now.

Features What Is The Real Value of Market Research?

What Is The Real Value of Market Research?

Layoffs at CPG companies have begun, including significant numbers in the research function at major corporations. Is healthcare market research insulated from this trend?

Features An Election Year Puts Pharma In The Spotlight

An Election Year Puts Pharma In The Spotlight

In a town where the main business is politics, the election of a new president heightens the intensity.

Features Leadership Exchange: Social Listening

Leadership Exchange: Social Listening

Social listening can help all along the value chain—from research and discovery to developing marketing plans and strategy.

Features What WWE Taught Me About EHR Promotion

What WWE Taught Me About EHR Promotion

How did the WWE keep me interested for the last 20 years?

Features Lack of expertise limits pharma's Facebook use

Lack of expertise limits pharma's Facebook use

With few exceptions, pharma brands haven't made much headway on Facebook. Marketers won't see real results until they cede control and stop chasing likes.

Features What pharma companies and agencies can learn from Amazon

What pharma companies and agencies can learn from Amazon

In the wake of an exposé on Amazon's corporate culture, pharma companies and agencies strive to keep employees as happy and satisfied as their clients.

Therapeutic Focus New cardiovascular drugs raise concerns about pricing, efficacy

New cardiovascular drugs raise concerns about pricing, efficacy

With the huge advances in treatment comes a raft of concerns, among them daunting pricing pressures.

Features Wearables have yet to move past the hype

Wearables have yet to move past the hype

Wearables has been the buzziest of healthcare-related buzzwords. And yet here we are in January 2016, still awaiting their iPhone moment.

Features Baxalta's oncology chief builds out company's third leg

Baxalta's oncology chief builds out company's third leg

David Meek has been charged with building an oncology arm that matches the company's existing strengths in hematology and immunology.

Features Read the complete December 2015 Digital Edition

Read the complete December 2015 Digital Edition

Click the link below to access the Digital Edition of the December 2015 issue of MM&M, with all text, charts and pictures.

Features What Happens Now with Off-Label Communications?

What Happens Now with Off-Label Communications?

Anyone who thinks that the argument over off-label communications is just about marketing and sales is looking at the issue through very narrow blinders

Sponsored SkillSets: Data Management IMS Health

SkillSets: Data Management IMS Health

Features Private View: Barclay Missen

Private View: Barclay Missen

Healthcare promotion: Happiness isn't the only emotion

Features

Why the Holdup in Patient Portals?

Patient portals are clearly underutilized as a patient resource. Although their use is increasing among a population hungry for health information, what can industry do to foster and promote their use?

Features This time, it's non-personal promotion for device makers

This time, it's non-personal promotion for device makers

Big pharma has used multi­channel marketing for years and medical-device makers have long utilized inside sales, but neither has systematically cracked the code on developing effective and fully integrated sales and marketing programs.

Features Rare-Disease Precision Marketing Follows Precision Medicine

Rare-Disease Precision Marketing Follows Precision Medicine

There is another revolution that is waiting to happen: one in how we get orphan drugs to patients who need them and help them stay on track with treatment.

Features Leadership Exchange: Launching at the Speed of Digital

Leadership Exchange: Launching at the Speed of Digital

It's no secret that speed matters in customer interface. Marc Iskowitz settles into the moderator's seat to find out how biopharma—an industry not known for moving with rapidity—is digitally shifting its commercial model into a higher gear

Features Patient Marketing: Dissed Content?

Patient Marketing: Dissed Content?

Content marketing continues to strike fear into the hearts of pharma marketers. Doing it properly requires courage, commitment, creativity—and perhaps a little wiggle room to fail and learn. James Chase looks at three flagship OTC content programs that might lend a bit of inspiration to the Rx world

Data/Analytics Data Management: Not If, But When

Data Management: Not If, But When

Healthcare may seem to have been unscarred by the ongoing rash of high-profile cyber-attacks, at least compared with retail and financial organizations. But to hear security pros tell it, the industry is increasingly finding itself as much of a target as companies in other sectors—if not more of one. Karen Epper Hoffman surveys the potential damage

Commercial Outlook 2016: High Science, High Stakes

Outlook 2016: High Science, High Stakes

The year 2015 may have lacked a ­hall-of-fame debut on par with 2014's hep.-C launches, but the year featured its share of intrigue in the form of sky-high valuations forcing big organizations to adjust their M&A approach and more. In this Q&A, Jon Gardner, deputy news editor at EvaluatePharma's EP Vantage, reads the tea leaves and hands out some awards—including Company of the Year honors for a controversial candidate

Pipeline The Pipeline Report 2016: Big-Time Upside

The Pipeline Report 2016: Big-Time Upside

A peek at 159 aspiring agents, with profiles on 17 that could shoot to stardom. Rebecca Mayer Knutsen has the forecast

Legal/Regulatory Outlook 2016: A Pharma Pile-On

Outlook 2016: A Pharma Pile-On

To hear politicians tell it—especially the ones seeking President Obama's job—pharma is motivated by profit and needs to be brought to heel. The reality of the situation, inside DC and out, is just a tad more complex. Larry Dobrow takes a closer look at what might be coming down the policy pipeline Illustration by Alex Fine

Features Headliner: Weill Cornell Dean/Doc Gets High Marks

Headliner: Weill Cornell Dean/Doc Gets High Marks

"Partnering up in complete transparency is the best possible scenario for patients"

Features Editor's Desk: Three Problems Ailing the Health Hackathon

Editor's Desk: Three Problems Ailing the Health Hackathon

Hackathons are a dime a dozen in healthcare. But are they encouraging the community to collaborate on solving the most nettlesome problems, or merely to tinker on me-too solutions?

Features Read the complete November 2015 Digital Edition

Read the complete November 2015 Digital Edition

Click the link below to access the Digital Edition of the November 2015 issue of MM&M, with all text, charts and pictures.

Features MM&M Awards 2015: The Gold Club

MM&M Awards 2015: The Gold Club

Pharma marketers of all stripes came together on October 1 in New York City to celebrate another outstanding year's worth of work—and play Photos: Dan D'Errico

Features Washington Insider: Patient Power and Social Media

Washington Insider: Patient Power and Social Media

Would you expect that patient power exerted through social media might shake the job of a high-level FDA center director?

Features Back Talk: Who's Aiming for the Feet?

Back Talk: Who's Aiming for the Feet?

That 700% price hike created an issue that threatens years of pharma progress

Features Private View: Stephanie Berman

Private View: Stephanie Berman

Features A Gateway Drug to Less Pain and Suffering

A Gateway Drug to Less Pain and Suffering

Features Not a Pill Person? More a "Disease Person"?

Not a Pill Person? More a "Disease Person"?

Therapeutic Focus Therapeutic Focus: Neurology

Therapeutic Focus: Neurology

The neurology space is gearing up to shake free of its decade-long stagnancy, with sector leaders and runners-up alike angling to push the boundaries. What that means: Imminent advances in genetic sequencing, targeted treatments and diagnostics, all designed to get to the biological root of neurological disorders. Rebecca Mayer Knutsen explains

Features Leadership Exchange: Transforming Patient Advocacy

Leadership Exchange: Transforming Patient Advocacy

It's an entirely different day for patient advocacy, yet we've only scratched the surface. Advocates and their pharma counterparts discuss what's standing in the way of deeper collaboration. Marc Iskowitz chairs a lively debate

Campaigns Reel Marketing: Choose Your Own Adventure

Reel Marketing: Choose Your Own Adventure

To date, pharma marketers have viewed interactive video as more or less a curio—a tactic best assigned to next year's to-do list. But in doing so, they're missing a huge opportunity to connect in ways that more linear forms of advertising can't match. By way of IKEA and Coldplay, Mitch Apley explains

Data/Analytics Engaging HCPs: Beer or Tacos?

Engaging HCPs: Beer or Tacos?

As pharma marketers continue on their age-old quest to engage physicians, the either/or choice between reps and digital tactics has largely gone away in favor of programs that incorporate both. At the same time, certain segments of the business are still finding their way in the brave new digital world. Larry Dobrow surveys the scene

Data/Analytics The Programmatic Movement: A Programmatic Primer

The Programmatic Movement: A Programmatic Primer

Programmatic buying has started to take over the placement of digital ads, to the tune of $15 billion in 2015 sales. Is pharma in the process of following suit or will concerns about privacy and fraud dampen industry enthusiasm? Barbara Peck assesses the pros and cons

Careers Headliner: Spark CCO maps gene therapy vision

Headliner: Spark CCO maps gene therapy vision

"Gene therapy is a collection of small details. It's not a secret sauce."

MM&M Awards

2015 Judges

Choosing the best of the best is never easy. It is a challenging task. Our panel of more than 100 of the industry's top thinkers, opinion makers and creatives used their vast expertise and tried-and-true insight to score the hundreds of entries for the MM&M Awards 2015. Please see the attached pdf (below) to see this year's roster.

Features MM&M Awards 2015 Book of Winners: A Message From the Editor

MM&M Awards 2015 Book of Winners: A Message From the Editor

Welcome to this special showcase of the winning work from the MM&M Awards 2015

MM&M Awards Titanium Award—Best in Show: 2015

Titanium Award—Best in Show: 2015

Recognizes an exemplary campaign or marketing initiative that distinguishes itself as "best in show."

MM&M Awards Platinum Award—Outstanding Contribution to Healthcare: 2015

Platinum Award—Outstanding Contribution to Healthcare: 2015

Recognizes exceptional contribution to healthcare by an individual, a team, an organization, association or other relevant group.

Email Newsletters